
Evaluating Use Patterns of and Adherence to Medications for Benign Prostatic Hyperplasia
Keywords: prostate; prostatic hyperplasia; medication adherence; Medicaid; adrenergic alpha-antagonists; 5-ARI; 5α-reductase inhibitor; AB; α-blocker; BPH; benign prostatic hyperplasia; LUTS; lower urinary tract symptoms; Medi-Cal; California Medicaid; MM; multip